Ibex Wealth Advisors Makes New Investment in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Ibex Wealth Advisors acquired a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report) during the 4th quarter, Holdings Channel reports. The firm acquired 16,359 shares of the exchange traded fund’s stock, valued at approximately $1,473,000.

Other institutional investors and hedge funds also recently modified their holdings of the company. Avior Wealth Management LLC grew its stake in SPDR S&P Biotech ETF by 393.6% in the 4th quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock valued at $35,000 after buying an additional 307 shares during the last quarter. Tidemark LLC grew its position in shares of SPDR S&P Biotech ETF by 101.5% in the third quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock valued at $39,000 after purchasing an additional 199 shares during the last quarter. Quintet Private Bank Europe S.A. bought a new position in shares of SPDR S&P Biotech ETF during the third quarter worth approximately $40,000. ORG Wealth Partners LLC acquired a new stake in SPDR S&P Biotech ETF during the 3rd quarter worth approximately $44,000. Finally, Howe & Rusling Inc. bought a new stake in SPDR S&P Biotech ETF in the 3rd quarter valued at $49,000.

SPDR S&P Biotech ETF Price Performance

NYSEARCA XBI traded up $0.33 on Wednesday, reaching $93.51. The stock had a trading volume of 888,417 shares, compared to its average volume of 8,909,880. The company has a market cap of $7.13 billion, a P/E ratio of 11.47 and a beta of 1.11. The firm has a fifty day moving average of $93.35 and a two-hundred day moving average of $96.83. SPDR S&P Biotech ETF has a 1-year low of $81.14 and a 1-year high of $105.47.

About SPDR S&P Biotech ETF

(Free Report)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Featured Articles

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.